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Summary 
The specificity of the T cell receptor (TCR) repertoire for foreign peptide bound to self-major 
histocompatibility complex (MHC) molecules is determined in large part by positive and negative 
selection processes in the thymus, yet the mechanisms of these selection events remain unknown. 
Using in vitro organ culture of thymi isolated from mice transgenic for a TCR.-ot/3  specific 
for cytochrome c peptide bound to  I-E  k,  we analyzed the developmental timing of negative 
selection (deletion).  On  the basis  of the experiments described below,  we conclude that  all 
CD4 +8 +  thymocytes, and  only CD4 +8 +  thymocytes, are  susceptible  to  negative  selection 
mediated by the cytochrome  c peptide antigen. First, we found that deletion of thymocytes resulting 
from addition of the cytochrome c peptide to the thymic organ cultures can occur at the earliest 
stage of TCR,  CD4,  and CD8  coexpression.  Second, we found that  CD4+8 +  thymocytes 
isolated from positively selecting or nonselecting MHC haplotyes were equally effaciently deleted 
in vitro, suggesting that positive selection is not a prerequisite for deletion. Third, we examined 
the effects of TCR/ligand  avidity on the developmental timing of deletion by varying the 
concentration of cytochrome c peptide added to the organ cultures. We detected deletion only 
at the CD4+8 §  stage:  intermediate concentrations of peptide that resulted in partial deletion 
of CD4 +  8 + cells did not eliminate the appearance of mature CD4 +  8-  cells. Finally,  we found 
that  CD4+8-  thymocytes were resistant to deletion as well as activation by peptide antigen 
added to the intact organ cultures. Nevertheless, the CD4§  -  thymocytes isolated from the 
peptide-treated organ cultures responded vigorously to peptide presented by spleen cells in vitro. 
Thus,  the T  cells were tolerant of (but not anergized by) self-antigen encountered in thymic 
organ culture. Together, these results indicate that thymocytes susceptible to negative selection 
are not developmentally distinct from those susceptible to positive selection, and further, that 
the thymic microenvironment plays a role in regulating the outcome of TCR/ligand interactions. 
T 
he reactivity of the TCR repertoire for foreign peptides 
bound to self-MHC is ensured by two selection processes 
in the thymus. We and others have shown that immature 
(CD4+8 +) T  cells expressing receptors specific for foreign 
peptides bound to self-MHC molecules are induced to differen- 
tiate into mature (CD4§  -  or CD4-8 +) cells by the rec- 
ognition of those self-MHC molecules, a process called posi- 
tive selection (1-6). In contrast, thymocytes bearing receptors 
specific  for self-peptide/MHC  complexes expressed in the 
thymus are eliminated during development, a process called 
negative selection (5, 7-10).  How signaling through the same 
TCR can result in two completely different outcomes is a 
major paradox ofT cell development. Three hypotheses have 
been proposed to resolve this paradox. First, it has been pro- 
posed that thymocytes susceptible to negative selection are 
developmentally distinct from thymocytes susceptible to posi- 
tive selection. Second, it has been proposed that the affinity 
of the TCR-peptide/MHC  interaction determines its out- 
come,  with  weakly binding  thymocytes being  positively 
selected and strongly binding thymocytes being deleted. Fi- 
nally, it has been proposed that specific thymic APC deter- 
mine the outcome of a TCR-peptide/MHC interaction by 
modifying the primary signal through the TCR via addi- 
tional cell surface interactions (reviewed in reference 11). 
A first step in the resolution of the T cell selection paradox 
is the determination of the developmental timing of thymic 
selection events.  In vivo studies of the negative selection of 
self-peptide/MHC reactive thymocytes in TCtL transgenic 
mice showed deletion of most (but not all) CD4 +  8 + cells 
(5,  10,  12). Since thymocytes are continuously developing 
in vivo, and since the timing of expression of the antigens 
mediating deletion is unknown, these studies do not rule out 
the possibility that only a subset of CD4 +  8 + thymocytes are 
susceptible to deletion. In contrast to the experiments de- 
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antigen-reactive T  cells in normal mice have indicated that 
deletion occurs late in the CD4 § 8 + stage (13,  14) or at the 
transition  from CD4+8 + to CD4 + or CD8 + (15). 
The experiments of Pircher et al. (16) provide an attractive 
explanation for the observed differences in the timing of de- 
letion mediated by superantigens as compared with conven- 
tional  MHC/peptide  antigens.  Using  a  transgenic  strain 
bearing  a  TCR reactive  to both  Mls  a superantigen  and  a 
conventional MHC-restricted viral antigen lymphocytic cho- 
riomeningitis virus, they examined the developmental timing 
of deletion mediated by these two antigens. They found that 
the Mls  a superantigen  deleted thymocytes at  the CD4+8 + 
to CD4-8 + transition and the viral antigen deleted thymo- 
cytes at the more immature CD4+8 + stage.  To explain their 
results,  the authors  speculated that  the timing  of deletion 
could depend on the avidity of the TCR for the deleting ligand. 
For example, high-avidity interactions (in their system, viral 
antigen)  would cause deletion early in the CD4+8 + stage 
(when cells have very low levels of TCR/CD3),  and low- 
avidity interactions  (such as Mls  ~) would occur later in the 
CD4+8 + stage, or at the CD4+8 + to CD4 + or CD8 + tran- 
sition,  when TCR/CD3  levels have been upregulated. 
The hypothesis that  avidity controls the timing  of delo- 
tion has  not been directly addressed in a system where the 
relative affinities of TCR/antigen interactions are known. Fur- 
thermore,  the in vivo analyses  of deletion described above 
have not taken into account the levels, developmental timing, 
or anatomical location of expression of antigens in the thymus. 
As a result, these in vivo studies have not been able to resolve 
the question of when and by what mechanism developing 
thymocytes gain  and lose their  susceptibility to deletion. 
We have overcome these difficulties by using in vitro thymic 
organ culture of TCR transgenic mice to study the develop- 
mental timing of deletion. This system allows manipulation 
of the time and concentration at which a specific antigen is 
encountered by developing T  cells, providing an advantage 
not present in in vivo systems. Specifically, we have analyzed 
T cell selection in thymic organ cultures derived from trans- 
genic mice expressing the 2B4 TCR on >95%  of thymo- 
cytes (1). In this transgenic strain, in contrast to others (10), 
the transgene-encoded  TCR is expressed efficiently on de- 
veloping T  cells.  Thus,  thymocytes expressing endogenous 
receptors are rare, even under selection pressure (1; this study). 
The  2B4 TCR,  originally  isolated from  the T  helper  hy- 
bridoma,  2B4 (17,  18),  is specific  for the carboxy-terminal 
fragment of the pigeon cytochrome c (PCC) 1 protein bound 
to the MHC class II molecule,  I-E  k.  2B4 + T  cells also re- 
spond "~10-50 times more strongly to the homologous pep- 
tide of moth cytochrome c (MCC) bound to I-E  k than  to 
PCC bound to I-E  k (17,  19;  our unpublished  results). 
Using this system we have been able to determine at which 
points in development thymocytes gain  and lose their sus- 
1Abbreviations used in this  paper: MCC, moth cytochrome  c; PCC, pigeon 
cytochrome c. 
ceptibility to deletion. Furthermore,  we have examined the 
effects of prior  positive  selection  as well as  differences in 
TCR/ligand  avidity on the developmental timing  and effi- 
ciency of deletion. 
Materials  and Methods 
Mic~  2B4 transgenic (9) and nontransgenic B10.BR/SgSnJ and 
C57 B1/10J (obtained from The Jackson Laboratory, Bar Harbor, 
ME) mice were maintained  and bred under  standard conditions. 
Pregnancies were timed  from the first day of plug observation 
(day 0). 
Tkymic Organ Cultures.  Fetal  thymi were cultured  according 
to procedures previously described (20, 21). Briefly, thymic lobes 
were removed from fetuses on day 14 or 16 as indicated. A small 
piece of liver was removed from each fetus for genotype determina- 
tion.  Lobes were placed on a strip of nitrocellulose supported by 
a sterile gelatin sponge (Upjohn Co., Kalamazoo, MI) soaked in 
RPMI/10%  FCS  plus  5  x  10 -s  M  ~-mercaptoethanol,  gen- 
tamycin, penicillin, and streptomycin.  Cultures  were fed on the 
third day by complete medium replacement. Newborn thymic cul- 
tures were established similarly, except that each thymus was cut 
into six pieces using small curved scissors. Each experiment  was 
repeated at least three times (unless otherwise noted in the figure 
legend),  and a representative example is given in the figures. 
Genotype Determinations.  The liver fragments were dissociated 
by rapid pipetting,  and the cells pelleted, resuspended, lysed, and 
amplified by the PCR as has been previously described (22). 1 gl 
of each sample was analyzed by simultaneous PCR using primers 
specific for the two 2134 TCR transgenes, and primers specific for 
the relevant H-2  k and H-2  b MHC alleles. 
FACS  ~ Analysis.  Directly conjugated rat anti-mouse CD4-PE- 
conjugated  (clone GK1.5) (23) and directly conjugated  rat anti- 
mouse CD8-red 613-conjugated  (clone 53-6.7) (24) mAbs were 
purchased from Gibco-BRL (Gaithersburg, MD). Other antibodies 
used were hamster anti-mouse CD3 (clone 500A2) (25), biotinylated 
anti-V~3 (clone KJ25) (26), and FITC-conjugated anti-2B4 c~ chain 
(done A2B4-2) (18). FITC-conjugated goat anti-hamster IgG-con- 
jugated affinity-purified antibody was purchased from Ca]tag. Cul- 
tured thymic organs were dissociated and the cells stained using 
above reagents for CD4, CD8, and CD3 simultaneously, and in 
some cases, parallel samples were stained for CD4, V~3, and clono- 
typic 2B4 o~ chain. Flow cytometric analysis was performed on a 
FACScan  |  instrument  (Becton Dickinson & Co., Mountain View, 
CA).  Ungated data (20,000-30,000  events per sample) were col- 
lected in list mode using FACScan  |  Research software and ana- 
lyzed using LYSYS  software (Becton Dickinson & Co.). Before anal- 
ysis of antibody staining,  samples were gated on live cells based 
on forward and side scatter parameters. Sorting was done on a FAC- 
Star Plus  |  (Becton Dickinson & Co.; MIT Flow Cytometry Lab). 
Magnetic Bead Sorting.  Cells  were stained using biotinylated anti- 
CD4 or anti-CD8  (Gibco/BRL), avidin FITC (Cappel Laborato- 
ries,  Cochranville,  PA), and  biotinylated  magnetic  microbeads 
(Miltenyi Biotec). Stained and unstained populations  were sepa- 
rated using a magnetic column (Miltenyi Biotec, Bergish-Ghdbach, 
Germany), and the purity was determined by flow cytometry. Pu- 
rity of fractions was 80-90%. 
Antigenic Stimulation.  l& irradiated B10.BR (I-E  k) spleen cells 
were plated with  104-103 sorted  thymocytes in  triplicate  wells. 
After 48 h, each well was labeled for 16 h with [SH]thymidine (5 
/~Ci/ml), harvested on filter discs (Skatron, Inc., Sterling, VA), and 
counted in Biofluor (DuPont Co.,  Wilmington,  DE). 
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dissociated and 10  s thymocytes were plated per well of a 96-well 
round-bottomed dish with 10  s spleen adherent  cells in the pres- 
ence or absence of peptide. Spleen adherent cells were isolated by 
allowing dissociated spleen cells to adhere for 2-24 h in culture, 
washed to remove nonadherent  cells, and trypsinized. All the cells 
from each well were harvested  by vigorous pipetting at 24 h, counted 
using  eosin  Y  for  exclusion  of dead  cells, and  stained  with 
fluorochrome-conjugated antibodies (described above) against CD4, 
CD8,  and  2B4 c~.  20,000  ungated  events were collected  on a 
FACScan  |  instrument  in list mode using FACScan  |  Research soft- 
ware. To determine  the recovery of cells in a given experiment, 
the samples were gated to include only live cells based on forward 
and side scatter parameters, and to include only thymocytes based 
on expression of the 2B4 c~ transgene. The percentage of events 
present in this gate set was determined for each sample of thymo- 
cytes, plus and minus  added peptide,  and the recovery of 2B4 + 
CD4+8 § cells was calculated. 
Cell Cycle Analysis.  Cultured thymi or fresh bone marrow cells 
were dissociated, pelleted, and resuspended in 0.1% sodium citrate, 
50/~g/ml propidium iodide as previously described (27). DNA con- 
tent was determined by FACScan  |  analysis using Cellfit software 
(Becton Dickinson & Co.), which measures propidium iodide (FL2) 
fluorescence intensity height, width, and area on a linear scale. Data 
were gated to exclude doublets, and FL2 area analyzed using the 
SOBK function to generate cell cycle statistics (software by Becton 
Dickinson & Co.). 
Results 
Peptide Antigen-mediated Deletion Occurs at the Earliest Stage 
of TCR and Coreceptor Expression.  To determine the earliest 
stage at which developing thymocytes become susceptible to 
antigen-mediated deletion, we cultured thymic lobes isolated 
from mice on the  14th day of gestation.  The  14th day of 
gestation is 3 d before expression of CD4,  CD8,  or TCK 
in vivo (data not shown); CD4+8 + thymocytes are not ob- 
served in significant numbers until the 17th day of gestation. 
Organ-cultured thymic lobes from both transgenic and non- 
transgenic littermates were dissociated and analyzed each day 
beginning  at 2 d in culture (gestational day 14 plus 2 d in 
culture; 14+2). As shown in Fig. 1 A, the majority of thymo- 
cytes were CD4-  and CD8-  at day 14 + 2. After 3 d in cul- 
ture, day 14+3, the thymocytes began to coexpress CD4 and 
CD8. By day 14 + 5, the cukures contained significant numbers 
of CD4+8 -  and  CD4-8 +  thymocytes.  These  results  are 
consistent with previous reports describing normal develop- 
ment  of thymocytes in organ culture (28).  In addition,  in 
all cases >90% of organ cultured thymocytes expressed both 
chains of the transgenic  TCR. as detected by specific anti- 
bodies (data not  shown). 
To  study antigen-mediated  deletion,  MCC peptide was 
added to parallel cultures at day 14 + 1. As shown in Fig.  1 
A,  the addition  of MCC peptide to cultures  of nontrans- 
genic thymi had no effect on T  cell development.  In con- 
trast,  H-2  k 2B4 ol/~  transgenic  organ  cultures  showed a 
marked change in the CD4 vs. CD8 profile in the presence 
of peptide antigen  (Fig.  1 A).  In particular,  MCC peptide 
eliminated TCK transgenic  thymocytes before or immedi- 
ately after CD4 and CD8 expression (day 14+3). At no stage 
was CD4/CD8  coexpression observed on  thymocytes de- 
veloping in the presence of peptide.  The absolute number 
of total thymocytes recovered from transgenic lobes on day 
14 + 5 was reduced in the presence of peptide (Fig. 1 A). This 
result suggests that MCC peptide specifically deletes 2B4 trans- 
genic CD4+8 + thymocytes as soon as they are formed.  In 
similar experiments, we found that  a cytochrome c peptide 
variant containing an amino acid change that does not affect 
MHC binding but eliminates  the ability of the peptide to 
stimulate 2B4 T  cells (K to Q  at position 99 of MCC) (29) 
does  not  delete  2B4 +  T  cells  even  at  100  /~M  (data  not 
shown).  In addition,  we find that  essenti:~lly all CD4 + 8 + 
cells can be deleted by peptide, as <1% of the remaining cells 
express the CD4 molecule on their surface.  These results are 
in contrast to those predicted by the in vitro studies of Finkel 
et al. (30, 31), and the in vivo studies of Guidos et al.  (15). 
Their experiments  suggest that  only a subset of CD4+8 + 
cells,  and in particular the more mature subset, is sensitive 
to deletion by recognition  of self-antigen  in the thymus. 
The immediate susceptibility of TCR transgenic CD4 +  8 + 
thymocytes might have been due to the slightly higher av- 
erage levels of TCR we and others have found in TCR trans- 
genic strains relative to nontransgenic littermates (9, 32). In 
the thymic organ cultures we found that although the levels 
of TCR/CD3 expression on transgenic thymocytes were on 
average slightly higher than on those of nontransgenic litter- 
mates, most transgenic  thymocytes expressed TCR/CD3 levels 
comparable to nontransgenic thymocytes (Fig.  1 B). Further- 
more, we have not found any greater sensitivity of thymo- 
cytes expressing relatively higher levels of TCR to limiting 
amounts of peptide (data not shown). Therefore, we think 
it unlikely that  premature TCR upregulation  can account 
for the sensitivity to deletion of all the transgenic thymocytes. 
Positive Selection Is Not Required for Deletion.  It has been 
suggested that  positive selection is required before thymo- 
cytes are susceptible to deletion by self-antigen (15). This hy- 
pothesis  is compelling because it  can explain  how similar 
signals through the same TCR can induce either differentia- 
tion (positive selection) or deletion (negative selection). This 
model predicts that positive and negative selection act on dis- 
tinct populations of immature thymocytes that differ by the 
downstream  signals induced by TCR engagement. 
The molecular and cellular events of positive selection, or 
even the developmental stage at which they take place,  are 
not well understood. However, most evidence suggests that 
positive selection occurs at the CD4+8 + stage.  For example, 
the  presence  of a  TCR  high subset  of CD4+8 +  cells  very 
strongly correlates with the presence of selecting MHC al- 
leles in TCR transgenic mice (32-34; our unpublished results), 
suggesting  that  upregulation  of TCR levels  on  CD4 +8 + 
cells is the first observable consequence of positive selection. 
Moreover, kinetic studies of CD4 +  8 +  TCR  high thymocytes 
in  normal  mice  suggest  that  these  cells  are  postselection 
precursors to mature T cells (35). We have previously deter- 
mined  that  differentiation  of CD4+8 -  thymocytes in 2B4 
TCR transgenic mice is 20 times more efficient on the selecting 
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Figure  1.  Time course of dele- 
tion in fetal thymic organ culture. 
(A) Thymi from day 14 2B4 e~/B 
transgenic  or  nontransgenic  fetal 
mice were cultured in the absence 
or presence of I #M MCC peptide 
for the indicated number of days. 
Thymi were disrupted and the cells 
stained with anti-CD4, anti-CD8, 
and anti-CD3 mAbs as described in 
Materials  and  Methods￿9  Results 
shown are log-log dot plots of CD4 
vs. CD8 staining of cells previously 
gated on live cells based on forward- 
and  side-scatter  parameters￿9  The 
number of total thymocytes  _+ SD 
x  10 -s recovered at the day 14+5 
time point is shown in the upper 
right for each sample and condition. 
(B)  CD3  expression  levels  on 
CD4 + 8 + thymocytes (indicated in 
the box) from transgenic and non- 
transgenic  mice from  gestational 
day 14 thymi after 4 and 5 d in cul- 
ture are shown.  The vertical lines 
are for reference in comparing the 
different histograms. 
as compared with the nonselecting MHC background (1). 
Our  results  described  above  demonstrate  that  CD4+8 + 
thymocytes are susceptible to deletion as soon as they are 
formed, before TCR high CD4 § 8 § thymocytes are detected 
in fetal thymi (Fig. 1 B), suggesting that prior positive selec- 
tion is not required for deletion. However, we tested this 
directly by determining whether CD4 +  8 + thymocytes that 
developed  in  the  nonselecting  MHC  H-2  b  (I-E-)  back- 
ground, and thus were at least 20-fold less likely to have been 
positively selected, could be deleted by antigen. Since the non- 
positively selecting MHC haplotype is I-E-,  and therefore 
cannot bind or present cytochrome c peptide to 2B4 TCR 
transgenic thymocytes, peptide added to H-2  b thymic organ 
cultures has no effect  (data not shown). Therefore, we used 
a disrupted culture system to which we added APC bearing 
the  I-E  k MHC  protein  (36).  In  addition,  newborn  mice 
were used for these experiments  since they contain greater 
numbers of thymocytes than fetal  mice.  We isolated TCR 
transgenic thymocytes from newborn mice bearing either the 
H-2 k (selecting)  or  H-2 b (nonselecting)  MHC  alleles  and 
cocultured them with spleen adherent cells in the presence 
or absence of 1 #M MCC peptide. After 24 h, the cultures 
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sion of the transgenic TCR o~ chain, CD4, and CD8. Fig. 
2 shows a representative CD4 vs.  CD8 staining of 2B4 +, 
H-2  b,  or H-2  ~ thymocytes cultured in the presence  or ab- 
sence of peptide. We found that the percentage of CD4 +  8 + 
thymocytes  from the nonselective as well as the selective MHC 
backgrounds were reduced five- to sevenfold in the presence 
of peptide (Fig. 2). As shown in Fig. 3, regardless of MHC 
haplotype, the number of 2B4 + CD4+8 + thymocytes was 
significantly (p g  0.001, student's t test) reduced in the pres- 
ence compared with the absence ofMCC peptide. These data 
indicate that H-2  b and H-2  ~ thymocytes are equally suscep- 
tible to deletion despite the large difference in effidency of 
positive selection in the two haplotypes. 
It remained possible that some positive selection occurred 
during the coculture of H-2  b thymocytes with H-2  ~ spleno- 
cytes.  To  test  this,  FACS|  CD4+8 +  thymocytes 
were cocuhured with spleen adherent cells and analyzed for 
CD4,  CD8,  and TCR expression each day for 3 d.  In no 
case were 2B4 + CD4 +  8-  thymocytes observed at any time 
in the cultures. These experiments strongly suggest that spleen 
adherent cells are not sufficient  to positively select thymo- 
cytes in vitro. This result is consistent with experiments by 
one of us and others indicating that hematopoietically de- 
rived thymic stromal cells do not mediate positive selection 
in vivo (1, 37). Taken together, our results strongly suggest 
that  CD4+8 +  immature  thymocytes  are  susceptible  to 
antigen-mediated deletion before positive selection￿9 
TCR/Ligand Avidity Does Not Influence the Developmental 
Stage of Deletion.  Our results demonstrate that transgenic 
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Figure  2.  Peptide-mediated  deletion of H-2  b and  H-2  k CD4+8  + 
thymocytes.  Thymocytes  from  newborn  H-2  b and H-2  k mice as indicated 
were dissociated  and plated in suspension with H-2  k spleen cells in the 
presence or absence of 1/zM MCC peptide as described in Materials and 
Methods. After 24 h of cocultivation,  cells were stained  with antibodies 
against CD4, CD8, and the TCR transgenic  o~ chain, 2B4. Results  shown 
are log-log  dot plots of CD4 vs. CD8 staining.  Samples  were gated  based 
on scatter  parameters for live  cells and for transgene-e~pressing  cells. The 
percent of cells present in each quadrant is shown. 
thymocytes are susceptible to deletion very early in develop- 
ment. Pitcher et al. (16) have suggested that the avidity of 
the TCR-peptide/MHC interaction could determine the de- 
velopmental stage at which thymocytes  are deleted. We decided 
to test this model in our TCR transgenic thymic organ cul- 
ture system, in which we can sdectively alter the avidity of 
the TCR-peptide/MHC interaction by varying peptide con- 
centration. For these experiments, gestational day 16 mice 
were used since day 16 thymocytes developed  into mature 
CD4 +8- thymocytes more efficiently in organ culture than 
did thymocytes from day 14 mice (data not shown). Further- 
more, after I d in culture (day 16+ 1 or day 0 ofpeptide addi- 
tion), thymi were found to contain g50%  CD4+8 +,  and 
no detectable CD4+8 -  (Fig. 4 A), allowing us to assess the 
effects of peptide on thymocytes undergoing the CD4 § 8 + 
to CD4 +  8- transition. The thymi used were obtained from 
heterozygous H-2  k/b mice, which express twofold less I-E on 
their MHC class II-positive ceils than homozygous H-2  k 
mice. MCC peptide was added at the indicated concentra- 
tion on day 16 + 1, and samples were stained with antibodies 
against CD4 and CD8 on day 16+6  (Fig.  4 B). It can be 
seen that at the different pepdde concentrations at which de- 
letion is occurring (>0.01 #M), the percentage of CD4 +  8- 
cells is reduced roughly in proportion to the reduction of 
the CD4+8 + population. We counted the number of cells 
present in cuhures on day 16 + 6 and calculated the number 
of thymocytes in each subset. As shown in Fig. 5, addition 
of peptide reduces  the total number of cells recovered  due 
to the elimination of CD4+8 + thymocytes. These results in- 
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Figure  3.  The absolute  number of2B4  + CD4+8  + thymocytes  recov- 
ered after 24 h in the presence or absence of peptide plus spleen  adherent 
cells (see Fig. 2 and Materials and Methods)  was determined  for 5 H-2  b 
and 6 H-2  k individual  animals. The average and standard  deviation  error 
bars are shown for each group, plus and minus peptide. 
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Figure 4.  MCC peptide titration fails to detect a difference  in the timing 
of deletion dependent on TCR avidity. Results shown are log-log dot plots 
of CD4 vs. CD8 staining of cells previously gated on live cells based on 
forward and side scatter parameters, as described in Materials and Methods. 
Day 16 fetal  thymi from 2B4 ~//3 transgenic  mice were cultured for 
6 d in the presence of varying concentrations  of MCC peptide. To demon- 
strate that the majority of CD4+8 -  thymocytes  present  on day 6 arose 
in organ cultures during this time period,  CD4 and CD8 expression on 
thymocytes  of a representative  thymus  analyzed on day 16+1 (day 0 of 
peptide  addition)  is shown in A. (B) CD4 vs. CD8 expression at day 6 
for thymi incubated  in concentrations  of peptide  varying from 0.003  to 
1/~M are shown.  At intermediate  concentrations  of peptide,  e.g., 0.03 
/~M, only partial  deletion  of CD4+8 § thymocytes  is observed with no 
visible effect on CD4 + cells; at high concentrations  of peptide,  e.g.,  1 
#M, both subsets of cells are gone. This experiment  was repeated in its 
entirety once with identical  results. 
dicate that CD4 § 8 § thymocytes are deleted at very low pep- 
tide concentrations,  and that cells in transition to becoming 
CD4 § 8- thymocytes are not preferentially susceptible to de- 
letion by levels of antigen that fail to delete CD4+8 § cells. 
CD4 +  8-  Thymocytes Are Resistant to Antigen-mediated De- 
letion.  To  determine  the  last  point  at  which  developing 
thymocytes are susceptible to antigen-mediated deletion, we 
added peptide to transgenic  thymic organ cultures after al- 
lowing the thymocytes to develop for several days in vitro. 
Again,  for these experiments gestational day 16 mice were 
chosen since day 16 thymocytes are initially CD4-8-,  yet 
ef~ciently  develop  into  mature  CD4+8 -  thymocytes  in 
organ culture. Day 16 fetal thymic organ cultures from 2B4 
o~//~ transgenic mice were established, and 1/~M MCC pep- 
tide was added on day 0, at which point CD4 +  8-  thymo- 
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Figure  5.  Culture of fetal thymi in the presence of MCC peptide pre- 
vents  the accumulation  of CD4+8 §  and  CD4+8 -  thymocytes.  Fetal 
thymic lobes cultured for 6 d, as described in the legends to Figs. 1 and 
4,  were dissociated and the cells counted.  The number of cells in each 
subset was calculated based on the quadrant  percentages shown in Fig. 4. 
cytes are undetectable, or on day 3, at which point CD4 +  8- 
cells are present representing 2-4% of thymocytes (data not 
shown). All cultures were analyzed on day 16 + 6. As shown 
in Fig. 6 A,  the addition  of peptide on day 0 led to a loss 
of both CD4 +  8 * and CD4 +  8- thymocytes. In contrast, ad- 
dition  of peptide  on  day  3  resulted  in  the  deletion  of 
CD4+8 + cells but not CD4+8 -  cells.  These data  suggest 
that CD4 + 8-  thymocytes are resistant to peptide-mediated 
deletion. 
The last point at which thymocytes are susceptible to de- 
letion, as well as the kinetics of deletion, were also examined 
in  thymi cultured from newborn mice.  The larger  size  of 
the newborn thymi allowed us to sample the same thymus 
at different time points and thus determine the kinetics of 
peptide-mediated deletion in vitro. Fragments of TCR trans- 
genic thymi were incubated in the presence or absence of pep- 
tide and analyzed for expression of CD4,  CDS,  and TCR 
at the indicated times.  12 h after the addition of peptide (1 
/~M),  we observed a twofold downregulation  of CD4 and 
CD8 (Fig. 6 B). A similar downregulation was an early re- 
sult of deletion observed in suspension cultures of TCR trans- 
genic thymocytes exposed to antigen (36). By 36 h, virtually 
all  CD4 +8 + cells  were eliminated  (Fig.  6 B).  In contrast, 
the CD4 +  8-  thymocytes appeared to be relatively resistant 
to antigen-mediated deletion. We next counted the number 
of cells present in cultures at the endpoint, 48 h, and calcu- 
lated the number of thymocytes in each subset.  As shown 
in Fig.  7,  slightly more CD4§  -  thymocytes,  and signifi- 
cantly fewer CD4 +8 + thymocytes, were present in cultures 
incubated in the presence vs. absence of peptide. We also de- 
termined the average  number of thymocytes present at the 
time  of peptide  addition,  and  found  that  most  CD4+8 - 
thymocytes present at 48 h were already present in the cul- 
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Figure  6.  CD4 +  8- cells are re- 
sistant to deletion in thymic organ 
cuhure. Results shown are log-log 
dot plots of CD4 vs. CD8 staining 
of cells previously  gated on live cells 
based on forward- and side-scatter 
parameters, as described in Materials 
and Methods. (.4) Fetal thymi from 
day 16 2B4 cz/fl transgenic mice 
were placed in organ culture, and 
analyzed  on day 16 + 6.1 #M MCC 
peptide was added to paralld cul- 
tures on day 0  or 3  of culture, 
as indicated. (B) The kinetics of 
antigen-mediated deletion of neo- 
natal thymocytes  in vitro are shown. 
Thymi  isolated  from  newborn 
transgenic mice were cut into frag- 
ments and then cultured in the ab- 
sence or presence of 1 #M MCC 
peptide for 12, 24, or 36 h, as indi- 
cated. A decrease in CD4 and CD8 
staining of CD4+8 + thymocytes  is 
visible after only 12 h, and by 36 h 
the bulk of these cells are deleted￿9 
In contrast, CD4 §  8- thymocytes 
are not deleted by peptide. Anti- 
CD3 staining profiles (log scale) of 
the CD4+8- (as shown in A) and 
CD4 +  8 + cells (B) are given in the 
right-most pand for the 36-h time 
",oint, plus and minus peptide. 
tures  at  time  0  (data  not  shown).  Thus,  the  CD4+8 - 
thymocytes resistant to deletion had not differentiated in the 
organ cultures in the presence of peptide.  In these experi- 
ments,  as well as those described previously, >95%  of the 
thymocytes (including CD4 +  8-  thymocytes in the presence 
of MCC peptide) expressed both chains of the transgenic TCK 
(data not  shown).  This result indicates that  CD4 +8 § but 
not CD4 § 8- thymocytes were deleted by peptide. The levels 
of TCR on CD4§  -  and CD4+8 + thymocytes in the pres- 
ence or absence of peptide were also examined.  As shown 
in Fig. 6 B, peptide was found to cause a TCK/CD3 down- 
modulation on the CD4 +  8- population.  Therefore, the de- 
letion resistance of CD4 +  8- thymocytes is not due to their 
inaccessibility to peptide. 
We tested whether the presence of peptide antigen might 
activate some of the CD4 +  8-  transgenic thymocytes in the 
organ cuhures,  and induce cell division.  If some CD4 § 8- 
thymocytes are deleted by peptide, and a resistant subset is 
induced  to  divide,  it  could  appear  that  the  number  of 
CD4+8-  thymocytes is  remaining  constant.  To assess  the 
proliferative activity of thymocytes in organ culture, we de- 
termined their DNA content by propidium iodide staining. 
Thymocytes were isolated after 48 h in organ culture in the 
presence or absence of peptide. The cells were permeabilized 
by hypotonic shock, nuclei stained with propidium iodide, 
and DNA content analyzed by FACS  |  (27). In both the pres- 
ence and absence of peptide, >90% of the thymocytes were 
in the G0/G1 stage of the cell cycle based on analysis of their 
DNA content (Fig.  8 A).  By comparison,  75% of normal 
mouse bone marrow ceils were in G0/G1 (Fig. 8 A). In other 
experiments, the cultured thymocytes were purified by mag- 
netic bead sorting into CD4 + and CD4-  fractions before 
DNA content analysis.  In these experiments  >90%  of the 
thymocytes were also in G0/G1,  in the presence or absence 
of peptide (data not shown).  We conclude that peptide did 
not induce the 2B4 transgenic thymocytes to divide in organ 
cultures. 
Expression of the Ib2 receptor c~ chain is induced on ma- 
ture T  cells by antigenic  stimulation  (38).  As an indepen- 
dent measure of the activation state of thymocytes in organ 
cultures, we analyzed the expression of the II,-2 receptor a 
chain on thymocyte subsets by three-color FACS  |  CD4 +  8- 
thymocytes did not express the IL-2 receptor a  chain with 
or without exposure to peptide (data not shown). These data 
indicate  that  2B4  TCR-c~/B-expressing  CD4+8 -  thymo- 
cytes are not activated by antigen before their exit from the 
thymus. 
We next determined whether thymocytes exposed to an- 
tigen in thymic organ culture could respond in conventional 
stimulation assays. This was of interest since the stimulation 
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Figure  7.  The absolute number of CD4+8- cells recovered from organ 
cultures after 2 d was the same or greater in the presence of peptide. Shown 
is the average plus standard deviation for two experiments in which thymic 
lobes from newborn mice were cultured 48 h in the presence or absence 
of peptide. Fragments representing a whole thymus lobe were pooled, dis- 
sociated, and counted using eosin Y uptake to discriminate live from dead 
cells. The fraction of CD4+8 § and CD4+8- cells was determined by an- 
tibody staining and FACS  |  analysis as described in Materials and Methods. 
of T cells in vitro by fixed APC (39), or by peptide presented 
by purified MHC in planar  membranes  (40),  has been ob- 
served to induce a state of antigen-specific proliferative non- 
responsiveness, termed anergy. Since peptide presented in organ 
culture was found not to activate CD4 +  8-  thymocytes, we 
hypothesized that they might be anergized. To test this, we 
determined the response of organ culture-derived thymocytes 
to peptide in conventional in vitro stimulation assays. Tram- 
genic thymi incubated for 48 h  in the presence or absence 
of  10  /.tM  MCC  peptide  were  separated  into  CD4+8 -, 
CD4 - 8-, and CD4- 8 +/CD4 +  8 + populations by magnetic 
bead sorting.  The purified cells were incubated in the pres- 
ence or absence of peptide with irradiated H-2  k spleen cells 
and pulse-labeled 48 h later with  [3H]thymidine.  All frac- 
tions from peptide-treated or untreated organ cultures were 
able to mount a vigorous proliferative response to antigen. 
As shown in Fig. 8 B, CD4§  -  thymocytes pretreated with 
peptide were found to respond two times better than their 
untreated counterparts.  Therefore, the CD4+8-  thymocytes 
were not  anergized by peptide in organ  culture. 
Discussion 
We have described a system useful for the analysis  of the 
molecular and cellular regulation of T cell selection. We have 
found that TCR transgenic thymi will develop faithfully in 
organ culture in vitro. This system has allowed us to manipu- 
late the  temporal  and quantitative  exposure of developing 
thymocytes to their peptide antigen.  Using this system, we 
have been able to determine the developmental time course 
of deletion susceptibility, and to test the predictions of models 
that have have been put forward to explain the developmental 
regulation  of T  cell selection. 
These experiments have demonstrated that deletion of self- 
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Figure  8.  (A) Thymocytes are not dividing in organ cultures with or 
without added pepdde. Representative samples of transgenic newborn thymi 
incubated  in the presence or absence of 10/~M MCC peptide  were ana- 
lyzed for DNA content as described in Materials and Methods.  Shown 
are frequency histograms of propidium iodide fluorescence area on a linear 
scale. Samples were gated  to exclude doublets.  The fluorescence areas 
representing  2 and 4 N  values of DNA content are noted on the lower 
panel. Cell cycle statistics based on the sum of  broadened rectangles (SOBR) 
model are given; in each case the goodness-of-fit of the data to the model 
was <3, where acceptable fit is <10. (B) Thymocytes  pretreated in organ 
culture with peptide show heightened response to peptide  presented by 
spleen cells in vitro. CD4+8 -  thymocytes  derived from organ cultures 
incubated  in the presence or absence of 10/~M peptide  were isolated by 
immtmomagneric bead separation as described in Materials and Methods. 
Triplicate wells of 1.5  x  10  4 cells from the sorted fractions were mixed 
with irradiated spleen cells with or without peptide, labeled 2 d later with 
[3H]thymidine,  harvested,  and counted. 
reactive thymocytes can occur at the earliest  CD4 § 8 + stage. 
In fact, in fetal organ cultures incubated with peptide from 
the initiation of culture, no CD4 +  8 + cells are ever observed. 
These results are consistent with a previous report indicating 
that  the superantigen SEB deletes newly formed VaS-bear- 
ing  CD4+8 +  thymocytes (41).  These  results  suggest  that 
thymocytes do not pass through an immature CD4 +  8 + de- 
velopmental  stage during  which they are resistant  to dele- 
tion,  as has been proposed (15,  30,  31). 
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sitive to deletion until after they have been positively selected 
(15). We find that thymocytes do not require prior exposure 
to positively selecting thymic epithelium to become suscep- 
tible to deletion. Thus, our results agree with those of others 
indicating that deletion can occur both before and after posi- 
tive selection (16,  32,  42).  These results argue against the 
model in which thymocytes progress through distinct de- 
velopmental stages during which they are first susceptible to 
positive selection and then to deletion. Instead, our results 
suggest that thymocytes are susceptible to deletion at the same 
developmental stage at which they are susceptible to positive 
selection. Significantly, these data imply that the outcome 
of TCR engagement may not be determined by developmen- 
tally regulated coupling of TCR signaling to distinct signal 
transduction mechanisms. Instead, the outcome of TCR en- 
gagement may be determined by the strength of the interac- 
tion, by modifications of the primary TCR signal by sec- 
ondary interactions determined by APC,  or both. 
We have extended this analysis further by testing the model 
proposed by Pitcher et al.  (16) to explain how, depending 
on the antigen, thymocytes bearing the same TCR. can be 
deleted either before or after positive selection (16). This model 
predicts that TCR/ligand  avidity determines the develop- 
mental stage at which thymocytes are deleted. By modulating 
the number of antigen receptor interactions, we have found 
no effect of TCR avidity on the developmental stage at which 
deletion takes place.  Our result indicates that avidity alone 
cannot explain the stage-specific  deletion observed for cer- 
tain antigens. 
Although clearly responsible for a large part of the toler- 
ance of the immune system to self-proteins, intrathymic de- 
letion cannot account for all instances of self-tolerance. There 
are many self-proteins that are not present in the thymus, 
and therefore are not able to induce deletion of reactive thymo- 
cytes. Nevertheless, the immune system makes no response 
to these peripheral self-proteins.  This problem, termed pe- 
ripheral tolerance, has been investigated using a variety of 
experimental protocols, which together reveal a variety of 
mechanisms of immune tolerance. For example, transgenic 
mouse strains that have been engineered to express  foreign 
proteins outside the thymus are usually tolerant to these pro- 
teins.  In one case, in vivo tolerance was correlated with the 
downregulation of reactive TCRs and CD8 coreceptors from 
the cell surface (43). In this experiment and others involving 
MHC antigens expressed on pancreas cells (44, 45), the toler- 
ance observed in vivo was found to be reversible  in vitro. 
Antigen-specific in vivo and in vitro nonresponsiveness or 
anergy was observed in another case (46).  In a third case, 
peripheral  tolerance  to  Mls  superantigens  occurred by  a 
nonthymus-dependent clonal elimination mechanism (47, 48). 
We  have  found  that  CD4+8 -  thymocytes exposed  in 
organ  culture  to  high  concentrations  of peptide  do  not 
proliferate. Our results are in contrast with those of  Jenkinson 
et al. (41), who showed that the superantigen SEB induces 
mature thymocytes to proliferate when added to day 14 fetal 
thymic organ cultures on the 16th day of culture. There are 
at least two possible explanations for this difference. First, 
it may be that conventional peptide/MHC complexes and 
superantigens differ in their ability to induce proliferation 
of thymocytes in organ culture. Alternatively, differences in 
the developmental stage of the responding thymocytes  or thymi 
may account for the different results obtained. In any case, 
our experiments do not rule out the possibility that some 
mature thymocytes may be capable of antigen-induced prolifer- 
ation in situ. For example, the thymocytes may need to be 
exposed to peptide for longer than 48 h in order to proliferate. 
CD4+8 -  thymocytes exposed in organ culture to high 
concentrations of peptide are not made anergic. Neverthe- 
less,  CD4+8 -  thymocytes contact their  antigen in intact 
organ cultures, since peptide induced a twofold downregula- 
tion of surface levels of TCR/CD3.  These results suggest 
that the thymic microenvironment plays a role in regulating 
the outcome of TCR/ligand interactions. The nonrespon- 
siveness and TCR downregulation of CD4+8 -  cells in in- 
tact thymi is perhaps most similar to the cases of peripheral 
tolerance to MHC expressed in transgenic pancreas or neu- 
roectodermal cells described above (43-45).  Since CD4 +  8- 
thymocytes are found primarily in the thymic medulla (49), 
our results suggest that the medullary APC of the organ- 
cultured thymus are, like pancreas or neuroectodermal cells, 
insuffcient to prime an immune response. This result was 
unexpected; although the thymic epithelium is readily toler- 
ated by allogenic graft recipients (50, 51), the hematopoietic 
stromal cells of nontreated thymic grafts, many of which re- 
side in the thymic medulla, are targets for graft ejection across 
allogeneic barriers (52). To resolve this issue it will be neces- 
sary to  determine which APC  are presenting peptides  to 
thymocytes in the medulla of cultured thymi. 
Our experiments have addressed the developmental stage 
requirements for antigen-mediated deletion in the thymus. 
This TCR transgenic thymic organ culture system should 
allow us to address other specific questions pertaining to the 
mechanisms of positive and negative selection. For instance, 
it may be possible to directly address the role of peptides in 
positive selection. Our data in Fig. 4 appear to show a slight 
increase in the efficiency of positive selection in the presence 
of low levels ofMCC peptide. More experiments are in prog- 
ress to determine if added peptides, whether MCC,  PCC, 
or substituted peptides with intermediate activities in stimu- 
lation assays (29),  have effects on the efficiency of positive 
selection. 
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